Back

Insilico Medicine shares jump 5.84% after foundation-model partnership

Verifying
  • Insilico Medicine announced a biology-focused foundation-model partnership with an unnamed laboratory.
  • Shares reached HK$64.35 and briefly gained approximately 5.84% after the announcement.
  • Insilico reported $106 million revenue and $35.54 million net profit in first-half 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.